GenomOncology

Together, we set the bar for cancer care.

Add To Watchlist
General Information
Company Name
GenomOncology
Founded Year
2012
Location (Offices)
Cleveland, United States +1
Founders / Decision Makers
Garreth Hippe - Chief Commercial Officer Brad Wertz - Chief Executive Officer Ian Maurer - Chief Technology Officer Jeffrey Smith - Senior Vice President Finance Justin Yeakley - VP of Product Development
Number of Employees
56
Industries
Analytics, Biotechnology, Health Care
Funding Stage
Debt Financing
Social Media

GenomOncology - Company Profile

GenomOncology, founded in 2012, is a pioneering company in the fields of Analytics, Biotechnology, and Health Care. With the slogan "Together, we set the bar for cancer care," GenomOncology is dedicated to providing the healthcare community with data-driven insights aimed at improving cancer care. By effectively transforming previously unusable data into actionable oncology treatment options and strategic insights, GenomOncology empowers precision oncology programs to achieve measurable results. The company's headquarters is located in the United States. In its latest funding round on 22 November 2019, GenomOncology secured a significant $1.39M in Debt Financing. This investment bolsters the company's potential for further growth within the healthcare technology sector.

Taxonomy: precision oncology, data-driven insights, cancer care, precision medicine, oncology treatment options, healthcare community, data transformation, clinical decision support, Molecular Tumor Board workflows, venture backed, Cleveland, OH, assay validation, collaborative decision support

Funding Rounds & Investors of GenomOncology (4)

View All
Funding Stage Amount No. Investors Investors Date
Debt Financing $1.39M - 22 Nov 2019
Venture Round Unknown 3
North Coast Ventures, investor in GenomOncology's Venture Round round Tri-Star Health Partners, investor in GenomOncology's Venture Round round Zapis Capital Group, investor in GenomOncology's Venture Round round
05 Feb 2014
Seed Round $250.00K 2
JumpStart, investor in GenomOncology's Seed Round round North Coast Ventures, investor in GenomOncology's Seed Round round
06 Jun 2012
Seed Round $1.25M - 01 Apr 2012

Latest News of GenomOncology

View All

No recent news or press coverage available for GenomOncology.

Similar Companies to GenomOncology

View All
Molecs - Similar company to GenomOncology
Molecs We learn from the puzzling nature of genome.
Aster Insights - Similar company to GenomOncology
Aster Insights Accelerating oncology medical product discovery and development through our scientific and clinical intelligence.
PreciseDx - Similar company to GenomOncology
PreciseDx Innovating breast cancer diagnostic testing with PreciseBreast
Aomics GmbH - Similar company to GenomOncology
Aomics GmbH Aomics is a global clinical data science CRO specialising in delivering end-to-end clinical biometrics solutions to SMEs
Genomate Health - Similar company to GenomOncology
Genomate Health The right drug. The first time. Every time.™ Computational-powered clinical decision support for precision oncology.
Circle Decoration Circle Decoration

Want to dive deeper into GenomOncology? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now